You are viewing a preview of...

Proteins for Serological Test of COVID-19

A luciferase immunoprecipitation system to clearly distinguish between infected and healthy cases

Background

  • Coronavirus disease (COVID-19) pandemic has caused more than 330,000 death and serious health problem world-wide
  • Early detection of the infection is important
  • Population immunity needs to check accurately
  • Quick detection method for cases with early infection and population-wide screening for immunity is needed
  • Cross-reactivity of antibody in the present commercially available detection methods is a problem

Technology Overview

  • Unique novel targets to SARS-CoV-2
  • Clearly distinguish between infected cases and normal control when compared with Protein S
  • Make use of luciferase immunoprecipitation system

Log in or create a free account to continue reading